Testing effectiveness (Phase 2)Active Not RecruitingNCT05669001What this trial is testingTCD601 in de Novo Renal Transplant RecipientsWho this might be right forRenal Transplantation ITB-Med LLC 76
Post-approval studies (Phase 4)Ended earlyNCT01371344What this trial is testingA Paediatric, Open, Follow up Study With Modigraf Examining Safety and Efficacy in de Novo Allograft RecipientsWho this might be right forHeart TransplantationKidney TransplantationLiver Transplantation Astellas Pharma Europe Ltd. 47
Testing effectiveness (Phase 2)Study completedNCT01780844What this trial is testingAssess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant RecipientsWho this might be right forKidney Transplantation Astellas Pharma Global Development, Inc. 149
Not applicableUnknownNCT01982903What this trial is testingProspective Study of Urinary Markers of Fibrosis in Kidney TransplantsWho this might be right forKidney Failure Universitaire Ziekenhuizen KU Leuven 180
Testing effectiveness (Phase 2)Study completedNCT00765661What this trial is testingPharmacokinetics of LCP-Tacro(TM) Once Daily And Prograf® Twice A Day in Adult De Novo Kidney Transplant PatientsWho this might be right forKidney FailureRenal Failure Veloxis Pharmaceuticals 63
Large-scale testing (Phase 3)Study completedNCT00239811What this trial is testingLong Term Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant RecipientsWho this might be right forRenal Transplantation Novartis Pharmaceuticals 684
Post-approval studies (Phase 4)Study completedNCT00240955What this trial is testingExtension Study of Enteric-coated Mycophenolate Sodium With Short-term or no Steroid Use Compared With Enteric-coated Mycophenolate Sodium With Standard Steroid Therapy in de Novo Kidney RecipientsWho this might be right forRenal Transplantation Novartis 79
Not applicableLooking for participantsNCT07081126What this trial is testingDaratumumab for Late Antibody-Mediated RejectionWho this might be right forKidney TansplantAcute Rejection (AR) of Transplanted Kidney University Hospital, Martin 20
Post-approval studies (Phase 4)Study completedNCT00229138What this trial is testingEfficacy and Safety of Enteric-Coated Mycophenolate Sodium (EC-MPS) in Kidney Transplant RecipientsWho this might be right forKidney Transplantation Novartis Pharmaceuticals 291
Testing effectiveness (Phase 2)Ended earlyNCT00555789What this trial is testing24 Month Extension to Efficacy and Safety of AEB071 Plus Tacrolimus (Converted to Mycophenolic Acid After 3 Months) in Renal Transplant Patients(Converted to Mycophenolic Acid After 3 Months) in Renal Transplant PatientsWho this might be right forKidney Transplantation Novartis Pharmaceuticals 137
Post-approval studies (Phase 4)Looking for participantsNCT05242315What this trial is testingExtended-Release Tacrolimus Following Liver TransplantationWho this might be right forLiver Transplant; ComplicationsRenal InsufficiencyImmunosuppressant Adverse Reaction+2 more University of Alberta 94
Testing effectiveness (Phase 2)Study completedNCT00239798What this trial is testingEfficacy and Safety of FTY720 in de Novo Adult Renal Transplant RecipientsWho this might be right forRenal Transplantation Novartis Pharmaceuticals 255
Post-approval studies (Phase 4)Study completedNCT00812123What this trial is testingCalcineurin Free Immunosuppression in Renal Transplant RecipientsWho this might be right forKidney TransplantationChronic Kidney Disease University Hospital, Basel, Switzerland 127
Testing effectiveness (Phase 2)Study completedNCT00106639What this trial is testingA 6-Month Study Of CP-690,550 Versus Tacrolimus In Kidney Transplant PatientsWho this might be right forKidney Transplantation Pfizer 61
Large-scale testing (Phase 3)Study completedNCT01276457What this trial is testingEverolimus in Combination With Cyclosporine Microemulsion in de Novo Renal Transplant RecipientsWho this might be right forTransplantation Infection Novartis Pharmaceuticals 223
Testing effectiveness (Phase 2)Study completedNCT00309907What this trial is testingEtanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell TransplantWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaBlastic Phase Chronic Myelogenous LeukemiaChildhood Acute Lymphoblastic Leukemia in Remission+22 more Children's Oncology Group 39
Not applicableStudy completedNCT00308802What this trial is testingNoninvasive Methods to Monitor Graft Survival in Kidney Transplant PatientsWho this might be right forKidney Transplantation National Institute of Allergy and Infectious Diseases (NIAID) 280
Early research (Phase 1)Active Not RecruitingNCT03726307What this trial is testingAllogeneic Regulatory Dendritic Cell (DCreg) Renal StudyWho this might be right forKidney TransplantRenal Transplant Recipients Angus W. Thomson PhD DSc 28
Large-scale testing (Phase 3)Ended earlyNCT00137345What this trial is testingStudy Comparing Sirolimus With Cyclosporine in a Calcineurin Inhibitor (CNI)-Free Regimen in Kidney Transplant RecipientsWho this might be right forKidney Transplant Wyeth is now a wholly owned subsidiary of Pfizer 500
Testing effectiveness (Phase 2)Study completedNCT00003408What this trial is testingBiological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With CancerWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more Cancer Treatment Centers of America 40